Education
About Us
Working with TipRanks
Follow Us
Xenon Pharmaceuticals (XENE)
NASDAQ:XENE
Xenon (XENE) Ownership Overview
0.10% Insiders
31.47% Mutual Funds
51.97% Other Institutional Investors
6.15% ETFs
10.30% Public Companies and
Individual Investors
The ownership structure of Xenon (XENE) stock is a mix of institutional, retail, and individual investors. Approximately 89.59% of the company’s stock is owned by Institutional Investors, 0.10% is owned by Insiders, and 10.30% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jun 06, 2025 | xxxxxxxxxxxxx | $91 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $10473896 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $203424130 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,538,691 | Institution | 5.87% | 195,526,808 | |
| 3,825,173 | Institution | 4.95% | 164,788,453 | |
| 3,396,073 | Institution | 4.39% | 146,302,825 | |
| 3,091,626 | Institution | 4.00% | 133,187,248 | |
| 2,094,013 | Institution | 2.71% | 90,210,080 | |
| 1,889,864 | Institution | 2.45% | 81,415,341 | |
| 1,430,758 | Institution | 1.85% | 61,637,055 | |
| 1,146,935 | Institution | 1.48% | 49,409,960 | |
| 1,077,880 | Institution | 1.39% | 46,435,070 | |
| 817,173 | Institution | 1.06% | 35,203,813 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,825,173 | Institution | 4.95% | 164,788,453 | |
| 3,091,626 | Institution | 4.00% | 133,187,248 | |
| 2,094,013 | Institution | 2.71% | 90,210,080 | |
| 1,889,864 | Institution | 2.45% | 81,415,341 | |
| 1,430,758 | Institution | 1.85% | 61,637,055 | |
| 1,146,935 | Institution | 1.48% | 49,409,960 | |
| 1,077,880 | Institution | 1.39% | 46,435,070 | |
| 817,173 | Institution | 1.06% | 35,203,813 | |
| 572,560 | Institution | 0.74% | 24,665,885 | |
| 568,203 | Institution | 0.74% | 24,478,185 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,843,223 | Institution | 2.39% | 77,839,307 | |
| 638,873 | Institution | 0.83% | 26,979,607 | |
| 545,667 | Institution | 0.71% | 23,043,517 | |
| 361,768 | Institution | 0.47% | 14,836,106 | |
| 145,782 | Institution | 0.19% | 6,280,289 | |
| 70,002 | Institution | 0.09% | 2,870,782 | |
| 68,873 | Institution | 0.09% | 2,908,507 | |
| 57,834 | Institution | 0.07% | 2,442,330 | |
| 56,807 | Institution | 0.07% | 2,447,246 | |
| 55,228 | Institution | 0.07% | 2,264,900 |
FAQ
Who Owns Xenon Pharmaceuticals (XENE)?
According to the latest TipRanks data, approximately 51.97% of the company's stock is held by institutional investors, 0.10% is held by insiders, and 10.30% is held by retail investors.
What percentage of Xenon Pharmaceuticals (XENE) stock is held by institutional investors?
According to the latest TipRanks data, approximately 51.97% of Xenon Pharmaceuticals (XENE) stock is held by institutional investors.
What percentage of Xenon Pharmaceuticals (XENE) stock is held by retail investors?
According to the latest TipRanks data, approximately 10.30% of Xenon Pharmaceuticals (XENE) stock is held by retail investors.
Who owns the most shares of Xenon Pharmaceuticals (XENE)?
Richard Driehaus owns the most shares of Xenon Pharmaceuticals (XENE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.